UBTECH Revenue Doubles; Humanoid Sales Up 268% Amid Losses: what are the key facts?

Total revenue for the first half of 2026 reached RMB 1.27 billion, a year-over-year increase of 104.2%.

UBTECH Revenue Doubles; Humanoid Sales Up 268% Amid Losses: what are the key facts?

Humanoid robot sales hit 16,123 units, marking a substantial year-over-year surge of 268.3%.

UBTECH Revenue Doubles; Humanoid Sales Up 268% Amid Losses: what are the key facts?

Revenue from full-size embodied AI products skyrocketed to RMB 590 million, up 1,445% year-over-year.

UBTECH Revenue Doubles; Humanoid Sales Up 268% Amid Losses: what are the key facts?

Adjusted EBITDA stood at negative RMB 170 million, indicating continued losses despite narrowed deficits.

Physix Frontier · News Briefing Card (enbrief · Aug 31, 2026)

UBTECH Revenue Doubles; Humanoid Sales Up 268% Amid Losses

KEY FACTS

Total revenue for the first half of 2026 reached RMB 1.27 billion, a year-over-year increase of 104.2%.
Humanoid robot sales hit 16,123 units, marking a substantial year-over-year surge of 268.3%.
Revenue from full-size embodied AI products skyrocketed to RMB 590 million, up 1,445% year-over-year.
Adjusted EBITDA stood at negative RMB 170 million, indicating continued losses despite narrowed deficits.

KEY DATA

RMB 1.27BTotal Revenue

16,123 unitsHumanoid Robot Sales

RMB 590MFull-Size Embodied AI Revenue

-RMB 170MAdjusted EBITDA

PHYSIX OBSERVATION

The industry is shifting from 'showcases' to 'workshops,' with UBTECH validating its commercialization path through genuine industrial orders. Despite explosive growth in revenue and sales, massive R&D investments keep the company in the red, while multi-front operations dilute resources. This marks the entry of humanoid robots into a brutal ROI assessment period; crossing the break-even point and solving home-scenario deployment challenges will be the key litmus tests for leading players.

Source: enbrief original report ↗